Evidence map›Paper›PMID 24418972›Full record

ArticleGut microbes

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.

Manuel Ferrer, Vitor A P Martins dos Santos, Stephan J Ott, Andrés Moya

Abstract readComment
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Review
  2. Review
  3. Gut microbes · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in colon-targeted drug technologies.Current opinion in gastroenterology · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. The implication of gut microbiota in recovery from gastrointestinal surgery.Frontiers in cellular and infection microbiology · 2023
    Review
  18. Article
  19. Gut microbiota in alopecia areata.Postepy dermatologii i alergologii · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Manuel FerrerConsejo Superior de Investigaciones Científicas (CSIC); Institute of Catalysis; Madrid, Spain.
Vitor A P Martins dos SantosChair of Systems and Synthetic Biology; Wageningen University; Wageningen, the Netherlands; LifeGlimmer GmbH; Berlin, Germany.
Stephan J OttInstitute for Clinical Molecular Biology at the Christian-Albrechts University; Kiel, Germany; Department for Internal Medicine; University Hospital Schleswig-Holstein, Campus Kiel; Kiel, Germany.
Andrés MoyaUnidad Mixta de Investigación en Genómica y Salud de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO); Salud Pública; Valencia, Spain; Instituto Cavanilles de Biodiversidad y Biología Evolutiva de la Universitat de València; Valencia, Spain; CIBER en Epidemiología y Salud Pública (CIBEResp); Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that the gastrointestinal tract (GIT) microbiota responds to different antibiotics in different ways and that while some antibiotics do not induce disturbances of the community, others drastically influence the richness, diversity, and prevalence of bacterial taxa. However, the metabolic consequences thereof, independent of the degree of the community shifts, are not clearly understood. In a recent article, we used an integrative OMICS approach to provide new insights into the metabolic shifts caused by antibiotic disturbance. The study presented here further suggests that specific bacterial lineage blooms occurring at defined stages of antibiotic intervention are mostly associated with organisms that possess improved survival and colonization mechanisms, such as those of the Enterococcus, Blautia, Faecalibacterium, and Akkermansia genera. The study also provides an overview of the most variable metabolic functions affected as a consequence of a β-lactam antibiotic intervention. Thus, we observed that anabolic sugar metabolism, the production of acetyl donors and the synthesis and degradation of intestinal/colonic epithelium components were among the most variable functions during the intervention. We are aware that these results have been established with a single patient and will require further confirmation with a larger group of individuals and with other antibiotics. Future directions for exploration of the effects of antibiotic interventions are discussed.

Indexed as

Anti-Bacterial AgentsBacteriabeta-LactamsGastrointestinal TractHumansMaleMicrobiotaAnti-Bacterial Agentsbeta-Lactamsantibiotic therapyhuman gut microbiotametabolomicmetagenomicmetaproteomicmetatranscriptomic

Identifiers

PMID24418972
PMCPMC4049940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.